rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Universal Health Services, Inc.

UHS · NYSE

Health CareProviders & FacilitiesAbove a falling average

UHS stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 10.2% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 34
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$1.3M
Officials’ trades on record
12

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$822K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

12 disclosed lines: House 9, Senate 1, executive 2; 8 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$100k–$250k10 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Arjun Mody Executive branch: Office of Government EthicsSocial Security Administrationsold$1k–$15k30 Jan 2026filed 10 Apr 2026
Julia Letlow House: U.S. House ClerkLA05bought$1k–$15k23 Oct 2025filed 13 Jan 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k18 Mar 2020filed 16 Apr 2020
Lizzie Fletcher House: U.S. House ClerkTX07sold$1k–$15k26 Feb 2019filed 23 Apr 2019
David B. McKinley House: U.S. House ClerkWV01sold$15k–$50k17 Dec 2018filed 9 Jan 2019
David B. McKinley House: U.S. House ClerkWV01bought$1k–$15k16 Oct 2017filed 9 Nov 2017
David B. McKinley House: U.S. House ClerkWV01soldjoint$1k–$15k21 Dec 2016filed 10 Jan 2017
David B. McKinley House: U.S. House ClerkWV01boughtjoint$15k–$50k18 Sep 2015filed 5 Oct 2015
Thomas MacArthur House: U.S. House ClerkNJ03sold$15k–$50k27 May 2015filed 7 Jun 2015
David B. McKinley House: U.S. House ClerkWV01bought$1k–$15k7 Mar 2014filed 30 Apr 2015

Insiders

Buy orders, 12 months0
Sale orders, 12 months4
Buyers · sellers0 · 2
WhoDidSharesTraded
Elliot J. Md Mba SussmanDirectorsold356at $193.3713 Mar 2026filed 13 Mar 2026
Elliot J. Md Mba SussmanDirectorsold318at $186.3511 Mar 2026filed 13 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Alan B. Miller Company insiderExecutive Chairman · last 27 May 20260 · 24
Eileen C. McDonnell Company insiderDirector · last 20 May 20261 · 8
Elliot J. Sussman Company insiderDirector · last 20 May 20260 · 7
Maria Ruderman Singer Company insiderDirector · last 20 May 20260 · 4
Nina Chen-Langenmayr Company insiderDirector · last 20 May 20261 · 2
Warren J. Nimetz Company insiderDirector · last 20 May 20260 · 5
Donald J. Trump Executive branchWhite House Office · last 10 Apr 20260 · 1
Alan Armstrong SenateSenator · last 27 Mar 20261 · 0
Edward H. Sim Company insiderExecutive Vice President · last 26 Mar 20260 · 0
Marc D. Miller Company insiderPresident and CEO · last 26 Mar 20260 · 26
Matthew Jay Peterson Company insiderExecutive Vice President, UHS · last 26 Mar 20260 · 4
Steve Filton Company insiderExecutive Vice President & CFO · last 26 Mar 20260 · 8

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202511.5%
Free cash flow marginFY 2025 · to 31 Dec 20254.9%
Return on capital employedFY 2025 · to 31 Dec 202516.2%
Cash conversionFY 2025 · to 31 Dec 2025125%
Debt to equityFY 2025 · to 31 Dec 20250.76×
Interest coverFY 2025 · to 31 Dec 202512.78×
Cash and equivalentsFY 2025 · to 31 Dec 2025$137.8M
Free cash flowFY 2025 · to 31 Dec 2025$849.2M

Analyst forecasts

No analyst forecasts yet.